[Hemoperitoneum from rupture of liver subcapsular hematoma after laparoscopic cholecystectomy attributed to ketorolac. Report of a case].
Ketorolac is one of the most common nonsteroidal anti-inflammatory drugs used to control postoperative pain. However, peri- and postoperative administration of ketorolac is associated with an increased risk of gastrointestinal bleeding as described in the literature. Notwithstanding this event is not frequent, it can expose the patient to serious complications that should be quickly recognised and effectively treated. We present a report about a female patient with cholelithiasis who underwent a laparoscopic cholecystectomy. After the operation, the patient had a haemorrhage that we attributed to surgery in a first time and then to administration of ketorolac.
Guercio
G
G
Azienda Ospedaliera Universitaria Policlinico P. Giaccone, Palermo, Dipartimento di Chirurgia Generale, d'Urgenza e dei Trapianti d'organo, Unità Operativa Complessa di Chirurgia Generale e Geriatria.
Sandonato
L
L
Cintorino
D
D
Ricotta
C
C
Diana
G
G
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D017081:Cholecystectomy, Laparoscopic; D005260:Female; D006406:Hematoma / Q000150:complications*; D006465:Hemoperitoneum / Q000209:etiology*; D006801:Humans; D020910:Ketorolac / Q000009:adverse effects*; D008107:Liver Diseases / Q000150:complications*; D012422:Rupture, Spontaneous
D000893:Anti-Inflammatory Agents; D020910:Ketorolac
Emoperitoneo da rottura di ematoma subcapsulare epatico indotto dal ketorolac dopo colecistectomia laparoscopica. Caso clinico.